Literature DB >> 30455249

The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.

Kyle T Helzer1, Mary Szatkowski Ozers1,2, Mark B Meyer3, Nancy A Benkusky3, Natalia Solodin1, Rebecca M Reese1, Christopher L Warren2, J Wesley Pike3, Elaine T Alarid4.   

Abstract

Posttranslational modifications are key regulators of protein function, providing cues that can alter protein interactions and cellular location. Phosphorylation of estrogen receptor α (ER) at serine 118 (pS118-ER) occurs in response to multiple stimuli and is involved in modulating ER-dependent gene transcription. While the cistrome of ER is well established, surprisingly little is understood about how phosphorylation impacts ER-DNA binding activity. To define the pS118-ER cistrome, chromatin immunoprecipitation sequencing was performed on pS118-ER and ER in MCF-7 cells treated with estrogen. pS118-ER occupied a subset of ER binding sites which were associated with an active enhancer mark, acetylated H3K27. Unlike ER, pS118-ER sites were enriched in GRHL2 DNA binding motifs, and estrogen treatment increased GRHL2 recruitment to sites occupied by pS118-ER. Additionally, pS118-ER occupancy sites showed greater enrichment of full-length estrogen response elements relative to ER sites. In an in vitro DNA binding array of genomic binding sites, pS118-ER was more commonly associated with direct DNA binding events than indirect binding events. These results indicate that phosphorylation of ER at serine 118 promotes direct DNA binding at active enhancers and is a distinguishing mark for associated transcription factor complexes on chromatin.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  DNA arrays; nuclear receptors; protein phosphorylation; protein-DNA interactions; steroid receptors; transcription factors

Mesh:

Substances:

Year:  2019        PMID: 30455249      PMCID: PMC6336141          DOI: 10.1128/MCB.00417-18

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  98 in total

1.  Regulation of estrogen receptor α N-terminus conformation and function by peptidyl prolyl isomerase Pin1.

Authors:  Prashant Rajbhandari; Greg Finn; Natalia M Solodin; Kiran K Singarapu; Sarata C Sahu; John L Markley; Kelley J Kadunc; Stephanie J Ellison-Zelski; Anastasia Kariagina; Sandra Z Haslam; Kun Ping Lu; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2011-11-07       Impact factor: 4.272

2.  Genome-wide analysis of estrogen receptor alpha DNA binding and tethering mechanisms identifies Runx1 as a novel tethering factor in receptor-mediated transcriptional activation.

Authors:  Joshua D Stender; Kyuri Kim; Tze Howe Charn; Barry Komm; Ken C N Chang; W Lee Kraus; Christopher Benner; Christopher K Glass; Benita S Katzenellenbogen
Journal:  Mol Cell Biol       Date:  2010-06-14       Impact factor: 4.272

3.  Nuclear receptor full-length architectures: confronting myth and illusion with high resolution.

Authors:  Fraydoon Rastinejad; Vincent Ollendorff; Igor Polikarpov
Journal:  Trends Biochem Sci       Date:  2014-11-28       Impact factor: 13.807

4.  Proteasome-dependent degradation of the human estrogen receptor.

Authors:  Z Nawaz; D M Lonard; A P Dennis; C L Smith; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.

Authors:  Tamika T Duplessis; Christopher C Williams; Steven M Hill; Brian G Rowan
Journal:  Endocrinology       Date:  2011-04-19       Impact factor: 4.736

6.  Sequence requirements for estrogen receptor binding to estrogen response elements.

Authors:  M D Driscoll; G Sathya; M Muyan; C M Klinge; R Hilf; R A Bambara
Journal:  J Biol Chem       Date:  1998-11-06       Impact factor: 5.157

7.  Dual roles of the transcription factor grainyhead-like 2 (GRHL2) in breast cancer.

Authors:  Stefan Werner; Sabrina Frey; Sabine Riethdorf; Christian Schulze; Malik Alawi; Lea Kling; Vida Vafaizadeh; Guido Sauter; Luigi Terracciano; Udo Schumacher; Klaus Pantel; Volker Assmann
Journal:  J Biol Chem       Date:  2013-06-29       Impact factor: 5.157

8.  Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase.

Authors:  S Kato; H Endoh; Y Masuhiro; T Kitamoto; S Uchiyama; H Sasaki; S Masushige; Y Gotoh; E Nishida; H Kawashima; D Metzger; P Chambon
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

9.  Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding.

Authors:  S F Arnold; J D Obourn; H Jaffe; A C Notides
Journal:  J Steroid Biochem Mol Biol       Date:  1995-11       Impact factor: 4.292

10.  GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility.

Authors:  Vasiliki Theodorou; Rory Stark; Suraj Menon; Jason S Carroll
Journal:  Genome Res       Date:  2012-11-21       Impact factor: 9.043

View more
  9 in total

1.  Translational offsetting as a mode of estrogen receptor α-dependent regulation of gene expression.

Authors:  Julie Lorent; Eric P Kusnadi; Vincent van Hoef; Richard J Rebello; Matthew Leibovitch; Johannes Ristau; Shan Chen; Mitchell G Lawrence; Krzysztof J Szkop; Baila Samreen; Preetika Balanathan; Francesca Rapino; Pierre Close; Patricia Bukczynska; Karin Scharmann; Itsuhiro Takizawa; Gail P Risbridger; Luke A Selth; Sebastian A Leidel; Qishan Lin; Ivan Topisirovic; Ola Larsson; Luc Furic
Journal:  EMBO J       Date:  2019-09-26       Impact factor: 11.598

2.  GRHL2 Enhances Phosphorylated Estrogen Receptor (ER) Chromatin Binding and Regulates ER-Mediated Transcriptional Activation and Repression.

Authors:  Rebecca M Reese; Kyle T Helzer; Kaelyn O Allen; Christy Zheng; Natalia Solodin; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2022-08-29       Impact factor: 5.069

Review 3.  Grainyhead-like 2 as a double-edged sword in development and cancer.

Authors:  Jiaxing He; Chunyang Feng; He Zhu; Shuying Wu; Peng Jin; Tianmin Xu
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

4.  Bone Marrow Stromal Cells Transcriptionally Repress ESR1 but Cannot Overcome Constitutive ESR1 Mutant Activity.

Authors:  David K Lung; Jay W Warrick; Peiman Hematti; Natalie S Callander; Christina J Mark; Shigeki Miyamoto; Elaine T Alarid
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

5.  Expression of Grainyhead-like 2 in the Process of Ductal Development of Mouse Mammary Gland.

Authors:  Shinya Matsuoka; Hiroyoshi Suzuki; Chieko Kato; Mai Kamikawa-Tokai; Akihiro Kamikawa; Yuko Okamatsu-Ogura; Kazuhiro Kimura
Journal:  J Histochem Cytochem       Date:  2021-05-14       Impact factor: 4.137

Review 6.  Estrogenic control of mitochondrial function.

Authors:  Carolyn M Klinge
Journal:  Redox Biol       Date:  2020-01-23       Impact factor: 11.799

7.  VULCAN integrates ChIP-seq with patient-derived co-expression networks to identify GRHL2 as a key co-regulator of ERa at enhancers in breast cancer.

Authors:  Andrew N Holding; Federico M Giorgi; Amanda Donnelly; Amy E Cullen; Sankari Nagarajan; Luke A Selth; Florian Markowetz
Journal:  Genome Biol       Date:  2019-05-13       Impact factor: 13.583

8.  FKBP52 and FKBP51 differentially regulate the stability of estrogen receptor in breast cancer.

Authors:  Makoto Habara; Yuki Sato; Takahiro Goshima; Masashi Sakurai; Hiroyuki Imai; Hideyuki Shimizu; Yuta Katayama; Shunsuke Hanaki; Takahiro Masaki; Masahiro Morimoto; Sayaka Nishikawa; Tatsuya Toyama; Midori Shimada
Journal:  Proc Natl Acad Sci U S A       Date:  2022-04-08       Impact factor: 12.779

9.  Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity.

Authors:  Kentaro Nishi; Wenqiang Fu; Ryoiti Kiyama
Journal:  PLoS One       Date:  2022-08-17       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.